Treatment strategies for peripheral artery disease (Q37519704)

20 August 2017

1 reference

title

Treatment strategies for peripheral artery disease (English)

1 reference

20 August 2017

Andrew B McCann

1

1 reference

20 August 2017

Michael R Jaff

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Expert Opinion on Pharmacotherapy

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

10

1 reference

20 August 2017

page(s)

1571-1586

1 reference

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Peripheral arterial disease: morbidity and mortality implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Physical activity during daily life and mortality in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Exercise training for claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Determinants of peripheral arterial disease in the elderly: the Rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Systematic review: smoking cessation intervention strategies for adults and adults in special populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Peripheral vascular effects of beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Statin therapy improves cardiovascular outcome of patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Thrombotic thrombocytopenic purpura associated with clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Patients with peripheral arterial disease in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Analysis of the cilostazol safety database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

L-arginine supplementation in peripheral arterial disease: no benefit and possible harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

European multicenter study on propionyl-L-carnitine in intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A dose-effect study of beraprost sodium in intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Cell therapy in peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The progression of lower limb atherosclerosis is associated with IgA antibodies against Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

A long-term study of policosanol in the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560902988502

Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.7326/0003-4819-144-9-200605020-00009

Identifiers

DOI

10.1517/14656560902988502

1 reference

20 August 2017

1 reference